AABB has installed Michael Murphy, MD, FRCP, FRCPath, FFPath, as its president for the 2018-2019 term. Murphy was inaugurated during the 2018 AABB Annual Meeting.
“It is a great honor for me to become the next president of AABB. I consider this role to be an important and challenging responsibility, but one that I undertake very willingly and respectfully,” said AABB’s new President Michael Murphy. “I will work with my colleagues on the Board of Directors and AABB’s CEO to continue to work to advance transfusion medicine, cellular therapies and patient blood management. Together, we will continue to adhere to AABB’s vision of making transfusion medicine and cellular therapies safe, available and effective worldwide.”
Read more: http://bit.ly/2P7EkUk.